Chemung Financial (CHMG) EBITDA (2010 - 2026)

Chemung Financial (CHMG) has 17 years of EBITDA data on file, last reported at $21.8 million in Q1 2026.

• On a quarterly basis, EBITDA fell 73.59% year-over-year to $21.8 million in Q1 2026; TTM through Mar 2026 was $107.5 million, a 61.19% decrease from a year earlier, with the FY2025 full-year figure at $67.2 million, down 19.55% from the prior year.
• EBITDA for Q1 2026 stood at $21.8 million, up from $21.4 million in the prior quarter.
• Over the last five years, EBITDA for CHMG reached as high as $124.6 million in Q3 2023 and fell as low as -$16.1 million in Q1 2023.
• Historically, EBITDA has averaged $32.0 million across 5 years, with a median of $20.0 million in 2023.
• Across the five-year window, EBITDA surged 1022.21% in 2023 and tumbled 96.53% in 2025, its largest moves.
• Year by year, EBITDA stood at -$13.1 million in 2022, then surged by 252.44% to $20.0 million in 2023, then dropped by 1.05% to $19.8 million in 2024, then increased by 7.96% to $21.4 million in 2025, then advanced by 2.22% to $21.8 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $21.8 million in Q1 2026, $21.4 million in Q4 2025, and $60.9 million in Q3 2025.